Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$946,103
-$208,237 QoQ
Shares Held
39,290
-4.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,357
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOWER BRIDGE ADVISORS holds $63,752,721 across 8 Drug Manufacturers - General names. PFE ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,561 | $22,745,806 | |
| 2 | NVS |
Novartis AG
|
69,416 | $10,878,875 | |
| 3 | ABBV |
AbbVie Inc.
|
38,900 | $9,788,796 | |
| 4 | LLY |
ELI LILLY & Co
|
6,601 | $7,917,438 | |
| 5 | AMGN |
Amgen Inc
|
15,102 | $5,468,736 | |
| 6 | MRK |
Merck & Co., Inc.
|
34,852 | $4,478,482 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
26,527 | $1,528,485 | |
| 8 | PFE |
Pfizer Inc
This page
|
39,290 | $946,103 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $946,103 | 39,290 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,154,340 | 41,109 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,247,490 | 50,100 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,429,428 | 56,100 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,379,571 | 56,913 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,621,455 | 63,988 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,724,370 | 64,997 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,843,506 | 63,701 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,835,208 | 65,590 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,776,749 | 64,027 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,912,433 | 66,427 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,301,235 | 69,377 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,405,401 | 65,578 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $7,310,503 | 179,179 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $9,201,115 | 179,569 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $7,857,939 | 179,569 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,545,825 | 182,068 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $9,709,152 | 187,544 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $11,206,036 | 189,772 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $8,196,501 | 190,572 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $7,483,554 | 191,102 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $6,732,367 | 185,823 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $7,215,348 | 196,016 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $6,194,183 | 168,779 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,555,212 | 169,884 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $5,545,006 | 169,884 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||